Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Protagonist Therapeutics Inc | 2,449,183 | 2,449,183 | 0 | $300.22M | $345.07M | 45.30% | +$44.84M |
| Nanobiotix S.A.ADS(NBTX) | 5,623,816 | 5,623,816 | 0 | $212.02M | $175.24M | 23.01% | -$36.78M |
| MeiraGTx Holdings plc(MGTX) | 6,641,064 | 6,641,064 | 0 | $89.72M | $73.05M | 9.59% | -$16.67M |
| Rapport Therapeutics, Inc.(RAPP) | 1,784,517 | 1,784,517 | 0 | $74.36M | $59.96M | 7.87% | -$14.40M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 1,979,173 | 1,979,173 | 0 | $32.44M | $26.56M | 3.49% | -$5.88M |
| Cerebras Systems IncCL A | 53,586 | 128,649 | +75,063 | $11.84M | $22.85M | 3.00% | +$11.01M |
| Xencor, Inc.(XNCR) | 748,062 | 748,062 | 0 | $12.04M | $18.66M | 2.45% | +$6.62M |
| Legend Biotech CorporationADS(LEGN) | 814,586 | 814,586 | 0 | $23.53M | $16.20M | 2.13% | -$7.32M |
| Fate Therapeutics, Inc.(FATE) | 3,379,064 | 3,379,064 | 0 | $9.12M | $8.01M | 1.05% | -$1.12M |
| CVRx, Inc.(CVRX) | 4,024,861 | 4,024,861 | 0 | $20.69M | $7.04M | 0.92% | -$13.64M |
| PROCEPT BioRobotics Corporation(PRCT) | 357,939 | 357,939 | 0 | $8.08M | $6.52M | 0.86% | -$1.56M |
| Neumora Therapeutics, Inc.(NMRA) | 1,849,445 | 1,849,445 | 0 | $3.14M | $1.10M | 0.14% | -$2.04M |
| Vor Biopharma Inc.(VOR) | 53,732 | 53,732 | 0 | $989.2K | $1.03M | 0.13% | +$36.0K |
| Standard BioTools Inc.(LAB) | 311,967 | 311,967 | 0 | $256.7K | $231.0K | 0.03% | -$25.6K |
| Adicet Bio Inc | 22,779 | 22,779 | 0 | $196.8K | $162.6K | 0.02% | -$34.2K |